The mechanisms underlying the dual effects of STIM1 on prostate cancer are complex, and a recent study showed that some genes or signals, such as TGF-β1, promote cell death and the EMT concurrently in the same types of cell line59. Here, STIM1 is linked to prostate carcinoma.